Global Colorectal Cancer Drugs Market 2019 Report

The report will be delivered in 2-3 business days.

Colorectal Cancer Drugs Global Market Report 2019

Purchase Options

Request Sample

Request For Discount

FAQ

Starting Price : $ 4000.00 | Pages : 200 | Published : December 2019 | SKU CODE : 7218 | Format :

The colorectal cancer drugs market consists of sale of colorectal cancer drugs. Colorectal cancer (CRC) or bowel cancer, is the cancer affecting large intestine and the rectum. They are also named, colon tumor or rectal cancer depending upon where they begin.

The global colorectal cancer drugs market was valued at about $8.1 billion in 2018 and is expected to decline to $7.97 billion at a CAGR of -0.4% through 2022.

North America was the largest region in the colorectal cancer drugs market in 2018. This region is expected to remain the largest during the next five years. The colorectal cancer drugs market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

The number of colorectal cancer worldwide has been increasing. According to the American Cancer Society (ACS) estimates, there will be around 101,420 new cases of colon cancer and around 44,180 new cases of rectal cancer that would be registered in the USA in 2019. The diagnosed incident cases of colorectal cancer are expected to increase by 27.3% to 672,400 cases by 2037. The reason for this increase can be attributed to factors such as low-fiber diet, obesity, consumption of alcohol and tobacco amongst others. The increase in number of colorectal cases will add to the overall size of the global colorectal cancer drugs market.

Increasing use of biologics and targeted therapies restrains the bladder cancer drugs market. Biologic therapy uses a body’s immune system to fight cancer rather than chemical drugs which reduces the body’s immune power. Targeted therapies block the growth and spreading of colorectal cancer even in stage IV where chemical drugs are ineffective. For example, some targeted therapies that have been approved to treat colorectal cancer include bevacizumab, cetuximab and panitumumab. The advantages of biologics drugs and targeted therapies over conventional chemical drugs might negatively influence the market.

Targeted therapies have already begun to extend the lifespan of metastatic Colorectal cancer patients compared with chemotherapy-only therapy. Target therapy includes hormone therapies, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery molecules. Targeted therapy is attaining importance due to its specificity toward cancer cells, while sparing the toxicity to off-target cells. Opdivo and Keytruda are examples of targeted therapies.

The colorectal cancer industry is governed by regulatory framework laid down by agencies such as US Food and Administration Agency (FDA), European Medicines Agency (EMA), American Society of Clinical Oncology (ASCO), and others. For instance, FDA's recommendation for colorectal cancer drugs industry in the form of guidelines are mentioned within the CFR 's (Code for Federal Regulations) title number 21 under part 312, that contains sub-parts from A to I. The sub-part E deals with the procedures designed to push the development, evaluation, and marketing of drugs related to therapies aimed to treat persons with life-threatening and illnesses such as colorectal cancer. It also includes guidelines for the monitoring and evaluation of clinical trials of colorectal cancer drugs and other cancer drugs by agency officials to determine whether new treatments are safe and effective, or better than existing treatments.

In April 2019, Bristol-Myers Squibb Company, an American pharmaceutical company got the approval to acquire Celgene corporation for $74 billion. The transaction is expected to create a leading specialty company which would address the needs of patients with cancer, inflammatory and immunologic disease and cardiovascular disease through high-value innovative medicines and leading scientific capabilities. Celgene corporation, a company that develops medicines for cancer and inflammatory disorders, was founded in 1996 and has its headquarters in the USA.

Major players in the market are Merck & Co. Inc, Roche, Sanofi, Amgen, PFIZER, INC.

1. Executive Summary

2. Colorectal Cancer Drugs Market Characteristics

3. Colorectal Cancer Drugs Market Size And Growth

3.1. Global Colorectal Cancer Drugs Historic Market, 2014 - 2018, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Colorectal Cancer Drugs Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Colorectal Cancer Drugs Market Segmentation

4.1. Global Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Vascular Endothelial Growth Factor (VEGF) Inhibitors

Epidermal Growth Factor Receptor (EGFR) Inhibitors

Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors

BRAF or MEK Inhibitors

Tyrosine Kinase (TKI) Inhibitors

Immunomodulators

4.2. Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Hospitals Pharmacies

Retail Pharmacies

Others

5. Colorectal Cancer Drugs Market Regional And Country Analysis

5.1. Global Colorectal Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

5.2. Global Colorectal Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Colorectal Cancer Drugs Market

6.1. Asia-Pacific Colorectal Cancer Drugs Market Overview

6.2. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

6.3. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

7. China Colorectal Cancer Drugs Market

7.1. China Colorectal Cancer Drugs Market Overview

7.2. China Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

7.3. China Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

8. India Colorectal Cancer Drugs Market

8.1. India Colorectal Cancer Drugs Market Overview

8.2. India Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

8.3. India Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

9. Japan Colorectal Cancer Drugs Market

9.1. Japan Colorectal Cancer Drugs Market Overview

9.2. Japan Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

9.3. Japan Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

10. Australia Colorectal Cancer Drugs Market

10.1. Australia Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

10.2. Australia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Colorectal Cancer Drugs Market

11.1. Indonesia Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

11.2. Indonesia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

12. South Korea Colorectal Cancer Drugs Market

12.1. South Korea Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

12.2. South Korea Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Colorectal Cancer Drugs Market

13.1. Western Europe Colorectal Cancer Drugs Market Overview

13.2. Western Europe Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

13.3. Western Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

14. UK Colorectal Cancer Drugs Market

14.1. UK Colorectal Cancer Drugs Market Overview

14.2. UK Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

14.3. UK Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

15. Germany Colorectal Cancer Drugs Market

15.1. Germany Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

15.2. Germany Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

16. France Colorectal Cancer Drugs Market

16.4. France Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

16.5. France Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Colorectal Cancer Drugs Market

17.1. Eastern Europe Colorectal Cancer Drugs Market Overview

17.2. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

17.3. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

18. Russia Colorectal Cancer Drugs Market

18.1. Russia Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

18.2. Russia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

19. North America Colorectal Cancer Drugs Market

19.1. North America Colorectal Cancer Drugs Market Overview

19.2. North America Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

19.3. North America Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

20. USA Colorectal Cancer Drugs Market

20.1. USA Colorectal Cancer Drugs Market Overview

20.2. USA Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

20.3. USA Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

21. South America Colorectal Cancer Drugs Market

21.1. South America Colorectal Cancer Drugs Market Overview

21.2. South America Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

21.3. South America Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

22. Brazil Colorectal Cancer Drugs Market

22.1. Brazil Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

22.2. Brazil Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

23. Middle East Colorectal Cancer Drugs Market

23.1. Middle East Colorectal Cancer Drugs Market Overview

23.2. Middle East Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

23.3. Middle East Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

24. Africa Colorectal Cancer Drugs Market

24.1. Africa Colorectal Cancer Drugs Market Overview

24.2. Africa Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

24.3. Africa Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

25. Colorectal Cancer Drugs Market Competitive Landscape And Company Profiles

25.1. Colorectal Cancer Drugs Market Competitive Landscape

25.2. Colorectal Cancer Drugs Market Company Profiles

25.2.1. Merck & Co. Inc

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Roche

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Sanofi

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. Amgen

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. PFIZER, INC.

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Colorectal Cancer Drugs Market

27. Colorectal Cancer Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Colorectal Cancer Drugs Market Future Outlook and Potential Analysis

30. Appendix

30.1. Abbreviations

30.2. Currencies

30.3. Research Inquiries

30.4. The Business Research Company

30.5. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2014-2018, $ Billion

Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion

Table 3: Global Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 4: Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 5: Global Colorectal Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 6: Global Colorectal Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 7: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 8: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 9: China, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 10: China, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 11: India, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 12: India, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 13: Japan, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 14: Japan, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 15: Australia, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 16: Australia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 17: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 18: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 19: South Korea, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 20: South Korea, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 21: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 22: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 23: UK, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 24: UK, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 25: Germany, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 26: Germany, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 27: France, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 28: France, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 29: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 30: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 31: Russia, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 32: Russia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 33: North America, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 34: North America, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 35: USA, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 36: USA, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 37: South America, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 38: South America, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 39: Brazil, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 40: Brazil, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 41: Middle East, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 42: Middle East, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 43: Africa, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 44: Africa, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 45: Merck & Co. Inc Financial Performance

Table 46: Roche Financial Performance

Table 47: Sanofi Financial Performance

Table 48: Amgen Financial Performance

Table 49: PFIZER, INC. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2014-2018, $ Billion

Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion

Figure 3: Global Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 4: Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 5: Global Colorectal Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 6: Global Colorectal Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 7: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 8: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 9: China, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 10: China, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 11: India, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 12: India, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 13: Japan, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 14: Japan, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 15: Australia, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 16: Australia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 17: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 18: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 19: South Korea, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 20: South Korea, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 21: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 22: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 23: UK, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 24: UK, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 25: Germany, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 26: Germany, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 27: France, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 28: France, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 29: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 30: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 31: Russia, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 32: Russia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 33: North America, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 34: North America, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 35: USA, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 36: USA, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 37: South America, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 38: South America, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 39: Brazil, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 40: Brazil, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 41: Middle East, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 42: Middle East, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 43: Africa, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 44: Africa, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 45: Merck & Co. Inc Financial Performance

Figure 46: Roche Financial Performance

Figure 47: Sanofi Financial Performance

Figure 48: Amgen Financial Performance

Figure 49: PFIZER, INC. Financial Performance

Research And Development Initiatives Taken In The Anti-Infective Drugs Market

Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry

Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends

Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021

View Report

Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022

Colorectal Cancer Drugs Global Market Report 2019

Research And Development Initiatives Taken In The Anti-Infective Drugs Market

Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry

Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends

Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021

Cardiovascular Drugs Global Market Report 2019

Dermatology Drugs Global Market Report 2019

Gastrointestinal Drugs Global Market Report 2019

Hematology Drugs Global Market Report 2019

Metabolic Disorders Drugs Global Market Report 2019

Musculoskeletal Disorders Drugs Global Market Report 2019

Call Us

+1 3156230293

+44 2071930708

+91 8897263534